Magellan Health, Inc. (NASDAQ:MGLN) SVP Jeffrey N. West Sells 1,109 Shares
Magellan Health, Inc. (NASDAQ:MGLN) SVP Jeffrey N. West sold 1,109 shares of the business’s stock in a transaction dated Thursday, July 20th. The stock was sold at an average price of $80.01, for a total value of $88,731.09. Following the transaction, the senior vice president now directly owns 15,040 shares of the company’s stock, valued at $1,203,350.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Shares of Magellan Health, Inc. (NASDAQ:MGLN) traded down 0.25% during trading on Friday, reaching $79.85. The company had a trading volume of 100,736 shares. Magellan Health, Inc. has a 52-week low of $49.50 and a 52-week high of $84.71. The company has a market capitalization of $1.89 billion, a P/E ratio of 23.31 and a beta of 0.59. The firm has a 50-day moving average price of $73.37 and a 200-day moving average price of $72.02.
Magellan Health (NASDAQ:MGLN) last issued its quarterly earnings data on Wednesday, April 26th. The company reported $0.74 earnings per share for the quarter, beating analysts’ consensus estimates of $0.70 by $0.04. Magellan Health had a return on equity of 9.05% and a net margin of 1.64%. The firm had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.33 billion. During the same quarter last year, the firm earned $0.79 EPS. Magellan Health’s quarterly revenue was up 16.9% on a year-over-year basis. On average, analysts predict that Magellan Health, Inc. will post $5.44 EPS for the current fiscal year.
WARNING: This piece of content was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/07/21/magellan-health-inc-nasdaqmgln-svp-jeffrey-n-west-sells-1109-shares.html.
A number of large investors have recently modified their holdings of MGLN. Howe & Rusling Inc. raised its stake in shares of Magellan Health by 27.7% in the first quarter. Howe & Rusling Inc. now owns 1,845 shares of the company’s stock worth $127,000 after buying an additional 400 shares during the period. Ameritas Investment Partners Inc. acquired a new stake in shares of Magellan Health during the first quarter worth $136,000. Credit Agricole S A acquired a new stake in shares of Magellan Health during the fourth quarter worth $151,000. State of Alaska Department of Revenue raised its stake in shares of Magellan Health by 4.4% in the first quarter. State of Alaska Department of Revenue now owns 2,620 shares of the company’s stock worth $180,000 after buying an additional 110 shares during the period. Finally, Eqis Capital Management Inc. acquired a new stake in shares of Magellan Health during the second quarter worth $210,000. Hedge funds and other institutional investors own 94.05% of the company’s stock.
A number of equities analysts have recently commented on the company. Zacks Investment Research raised Magellan Health from a “hold” rating to a “buy” rating and set a $90.00 price objective for the company in a research report on Tuesday. KeyCorp raised Magellan Health from a “sector weight” rating to an “overweight” rating and set a $91.00 price target for the company in a report on Thursday, July 13th. BidaskClub raised Magellan Health from a “sell” rating to a “hold” rating in a report on Tuesday, June 13th. Finally, Leerink Swann reaffirmed an “outperform” rating and issued a $73.00 price target (up from $68.00) on shares of Magellan Health in a report on Sunday, June 25th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $82.20.
Magellan Health Company Profile
Magellan Health, Inc is engaged in the healthcare management business. The Company’s segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC).
Receive News & Ratings for Magellan Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Magellan Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.